Investigator

Minghao Dang

Postdoctoral Fellow · University of Texas MD Anderson Cancer Center

MDMinghao Dang
Papers(1)
PPP2R1A mutations por…
Collaborators(10)
Mitsutake YanoR. Tyler HillmanRugang ZhangShannon N. WestinWeiyi PengAmir A. JazaeriAnil K. SoodAnnalyn WelpJennifer A. WargoJiakai Hou
Institutions(7)
The University Of Tex…The University of Tex…UC San Diego Health S…Pennsylvania Departme…University of HoustonWashington University…Unknown Institution

Papers

PPP2R1A mutations portend improved survival after cancer immunotherapy

Immune checkpoint blockade (ICB) therapy is effective against many cancers, although resistance remains a major issue and new strategies are needed to improve clinical outcomes

10Works
1Papers
15Collaborators
Kidney NeoplasmsDisease ProgressionCarcinoma, MedullaryOvarian NeoplasmsCell Line, TumorNeoplasmsLung Neoplasms

Positions

2019–

Postdoctoral Fellow

University of Texas MD Anderson Cancer Center

2018–

Postdoc

Duke University School of Medicine

2017–

Research Associate

Baylor College of Medicine

Education

2017

PhD

University of Chinese Academy of Sciences

Links & IDs
0000-0001-7287-2877